Articles
Daily market commentary and analysis.
The $20 Billion Counter-Drone Trade Most Investors Are Still Missing
Everyone bought the drone stocks. Now there’s a smarter play hiding in plain sight — the companies building systems to shoot them down. The Iran conflict has turbocharged what was already one of…
Apr 13, 2026
Insider Signals Flash Green on Nike and ThredUp Right Now
Nike insiders just made a major purchase after a 75% collapse in the stock price. And a director at ThredUp — a fast-growing online resale platform — just put real money down for the first time. When…
Apr 13, 2026
The IPO Trap: Why Waiting for the Bell Might Cost You Millions
Here’s the thing about AI IPOs that nobody’s talking about: the real money gets made before the stock ticker even starts moving. Right now, OpenAI, SpaceX, Anthropic, and Anduril are still private.…
Apr 13, 2026
When Peace Talks Bomb, Oil Prices Boom (And Your Portfolio Feels It)
So here’s the thing about geopolitics and your stock portfolio: they’re basically dating, and right now they’re having a really messy breakup. Over the weekend, VP JD Vance jetted off to Pakistan to…
Apr 13, 2026
Royalty Pharma Surged 25% in a Down Quarter — Here's Why Hedge Funds Love It
Q1 2026 was a rough quarter. The S&P 500 dropped 4.33%, Middle East tensions hammered energy prices, AI fears sparked a “SaaS-pocalypse,” and private credit markets were rattled enough that most…
Apr 13, 2026
Why the Smartest AI Trade Right Now Might Be Ignoring AI Stocks
Eric Fry made his name in the early 2000s by doing something that felt crazy at the time: walking away from the hottest tech stocks at the peak of the dot-com boom and buying the boring stuff…
Apr 13, 2026
Oil Surges Past $100 as Markets Quietly Stop Panicking Over Iran
Here’s a strange thing happening in financial markets right now: oil just blew past $100 a barrel, the U.S. is blockading the Strait of Hormuz, and stocks are barely flinching. If that feels…
Apr 13, 2026
Novo Nordisk's Bioprinting Bet Could Be a Game-Changer (Or Just Expensive Hype)
Novo Nordisk (NVO) is up 3.6% today after announcing a $2.6 billion partnership with Aspect Biosystems, and honestly? This could be the real deal—or it could be pharmaceutical theater. Let’s break it…
Apr 13, 2026
Anthropic's Revenue Just Did Something Absolutely Bonkers—And It Changes Everything About AI Investing
Remember Netscape? That scrappy browser company that went public in 1995 with zero revenue and somehow convinced the world it was worth billions? Its stock doubled on day one, and suddenly everyone…
Apr 13, 2026
Nine Wall Street Pros Spill: Where to Actually Put Your $10K When Markets Are Losing Their Minds
So the market’s been acting like a toddler on a sugar rush—one minute it’s up, the next it’s spiraling because of geopolitical drama. If you’ve got $10,000 burning a hole in your pocket and you’re…
Apr 13, 2026
Beyond Meat’s Billion-Dollar Collapse Is a Warning for Every Hype Stock
Once upon a time, Beyond Meat was worth $14 billion. Today it’s a penny stock fighting to stay listed on Nasdaq. The story of BYND’s fall from grace is one of the cleanest cautionary tales the market…
Apr 12, 2026
Novo Nordisk Launches Stronger Wegovy HD — Weight Loss Just Got More Aggressive
Novo Nordisk just handed the obesity drug market a new gear. The Danish pharma giant launched Wegovy HD — a higher-dose 7.2 mg version of its blockbuster weight-loss drug — across more than 70,000…
Apr 12, 2026
The Smartest AI Trade Right Now? Bet Against AI Stocks
Here’s a counterintuitive thesis from a veteran market strategist: the best way to profit from the AI boom might be to stop chasing AI stocks altogether. Eric Fry, the macro investor who correctly…
Apr 12, 2026
Citi's Earnings Season Cheat Sheet: 16 Stocks Ready to Make a Move
Earnings season is basically the Super Bowl of the stock market—everyone’s watching, everyone’s nervous, and someone’s definitely going to surprise you. Citi just dropped a playbook for investors…
Apr 12, 2026
Corporate Insiders Are Buying the Dip — and That Is a Bullish Signal
When the market sells off, the usual suspects come out with their predictions. Strategists warn of further downside. Retail investors panic-sell. But there is one group that tends to cut through the…
Apr 12, 2026
Big Bank Earnings Are This Week — and Valuations Are Actually Cheap
This is shaping up to be one of the most interesting bank earnings seasons in years. Yes, the macro backdrop is messy: an Iran war, oil volatility, a Fed that cannot make up its mind, and a consumer…
Apr 12, 2026
Trump's Hormuz Blockade: What It Means for Your Energy Portfolio Now
It’s official: the Strait of Hormuz — the narrow chokepoint through which roughly 20% of the world’s oil flows — is now under U.S. blockade. President Trump announced Sunday morning that the U.S.…
Apr 12, 2026
Can the Bull Market Keep Its Winning Streak in 2026?
The bull market’s been on a three-year tear, and Wall Street’s asking the obvious question: can it keep going? Here’s the thing—most analysts think yes, but they’re not all betting the same amount.…
Apr 12, 2026
Markets Just Pulled Off the Ultimate Plot Twist—And Nobody Saw It Coming
Remember when the Iran war had everyone convinced we were headed for an economic apocalypse? Yeah, about that. This week, markets decided to do a complete 180, and honestly, it was the financial…
Apr 12, 2026
Peace Breaks Out, Markets Go Bonkers—Here's What Actually Matters
Well, that was close. Like, *really* close. Yesterday at 6:30 p.m., Trump posted something that didn’t end with “and a whole civilization will die tonight.” Instead, it was a ceasefire announcement.…
Apr 12, 2026